RELAPSE/RECURRENCE
Clinical trials for RELAPSE/RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE/RECURRENCE trials appear
Sign up with your email to follow new studies for RELAPSE/RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo shows promise for tough-to-treat lymphoma
Disease control Recruiting nowThis study tests whether adding the experimental drug lacutamab to standard chemotherapy helps people with a rare type of blood cancer (peripheral T-cell lymphoma) that has returned or stopped responding to previous treatments. About 56 adults whose cancer cells have a specific m…
Matched conditions: RELAPSE/RECURRENCE
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New trial aims to find best treatment for returning leukemia
Disease control Recruiting nowThis study tests whether a gentler, low intensity therapy works better than strong chemotherapy for people whose acute myeloid leukemia (AML) has come back or not responded to treatment. About 339 adults with AML in their first or second relapse will be randomly assigned to one o…
Matched conditions: RELAPSE/RECURRENCE
Phase: PHASE3 • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated May 11, 2026 20:47 UTC